A pilot study of intensive short‐time continuous renal replacement therapy to substitute maintenance hemodialysis during transitional period of COVID ‐19
Therapeutic Apheresis and Dialysis · 2024
DOI: 10.1111/1744-9987.14083 ↗Kurz gefasst
Fachartikel in der Zeitschrift Therapeutic Apheresis and Dialysis, 2024. Verfasst von Jing Xu und 11 weiteren Autor:innen. Beteiligte Einrichtung: Department of Nephrology, Shanghai Changzheng Hospital, Second Military Medical University (Naval Medical University), Shanghai, China. Hauptthemen laut MEDLINE: Continuous Renal Replacement Therapy, Hemodiafiltration, COVID-19, Acute Kidney Injury. Die Arbeit nennt 17 Literaturangaben. Gefördert von: National Natural Science Foundation of China, Medical innovation research project of Shanghai Science and Technology Innovation Plan, Medical-enterprise integration innovation achievement transformation project.
Abstract (Originalsprache)
Introduction
There is a lack of perfect solutions for maintenance hemodialysis (MHD) in patients with a high transmission risk of SARS‐CoV‐2.
Methods
MHD patients with a high risk of SARS‐CoV‐2 transmission from April 1 to June 30, 2022, were recruited. We performed 4‐h continuous renal replacement therapy with Prismaflex dialysis machine and ST100 suite using continuous venovenous hemodiafiltration (CVVHDF) mode with a fluid exchange volume of 8000 mL/h.
Results
Forty‐five MHD patients were included with a median dialysis age of 91 months. Overall spKt/V reached 0.96 ± 0.19. Urea reduction ratio was 50.29 ± 7.60% with the ultrafiltration of 2.18 ± 0.79 kg. Dry weight was significantly inversely correlated with spKt/V ( R = −0.563, p < 0.001). Female gender was a significant positive factor of spKt/V. Preheating of replacement solution using an incubator solved the complication of shivering in most patients.
Conclusion
Intensive short‐time CVVHDF may be considered as an alternative for routine MHD during COVID‐19 transitional period.
Schlagwörter
MeSH-Schlagwörter (MEDLINE)
Stichwörter der Autor:innen
Autor:innen und Institutionen
- Department of Nephrology, Shanghai Changzheng Hospital, Second Military Medical University (Naval Medical University), Shanghai, China.
ORCID-Profile: Cheng Xue
Förderung
- National Natural Science Foundation of China
- Medical innovation research project of Shanghai Science and Technology Innovation Plan
- Medical-enterprise integration innovation achievement transformation project
- Changzheng Hospital Excellent Young Physician Program
Zitieren
APA
Xu, J., Xue, C., Cui, F., Lv, J., Jie, Y., Liu, L., Zheng, Q., Fang, H., Li, X., Dai, B., Chen, J., & Mao, Z. (2024). A pilot study of intensive short‐time continuous renal replacement therapy to substitute maintenance hemodialysis during transitional period of COVID ‐19. Therapeutic Apheresis and Dialysis. https://doi.org/10.1111/1744-9987.14083
Vancouver
Xu J, Xue C, Cui F, Lv J, Jie Y, Liu L, et al. A pilot study of intensive short‐time continuous renal replacement therapy to substitute maintenance hemodialysis during transitional period of COVID ‐19. Therapeutic Apheresis and Dialysis. 2024. doi:10.1111/1744-9987.14083
BibTeX
@article{Xu2024,
author = {Xu, Jing and Xue, Cheng and Cui, Fangzheng and Lv, Jiayi and Jie, Yanqing and Liu, Lingling and Zheng, Qianwen and Fang, Haigu and Li, Xiangdong and Dai, Bing and Chen, Jing and Mao, Zhiguo},
title = {A pilot study of intensive short‐time continuous renal replacement therapy to substitute maintenance hemodialysis during transitional period of COVID ‐19},
journal = {Therapeutic Apheresis and Dialysis},
year = {2024},
doi = {10.1111/1744-9987.14083}
}
EUVIMED